BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 19880446)

  • 1. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis.
    Iwata A; Watanabe N; Oya Y; Owada T; Ikeda K; Suto A; Kagami S; Hirose K; Kanari H; Kawashima S; Nakayama T; Taniguchi M; Iwamoto I; Nakajima H
    J Immunol; 2010 Jan; 184(1):127-33. PubMed ID: 19949073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
    J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
    Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
    Martin IV; Schmitt J; Minkenberg A; Mertens JC; Stieger B; Mullhaupt B; Geier A
    Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
    Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
    J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical contribution of liver natural killer T cells to a murine model of hepatitis.
    Takeda K; Hayakawa Y; Van Kaer L; Matsuda H; Yagita H; Okumura K
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5498-503. PubMed ID: 10792025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
    Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
    Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
    Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
    Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.
    Jiang W; Sun R; Zhou R; Wei H; Tian Z
    J Immunol; 2009 Mar; 182(6):3768-74. PubMed ID: 19265155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S; Moschetta A
    FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
    Biburger M; Tiegs G
    J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
    Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.